Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating chronic pelvic inflammation

A technology of chronic pelvic inflammatory disease and composition, applied in the direction of drug combination, drug delivery, disease, etc., can solve the problems of tubal adhesion, endocrine disorder, obstruction, etc., achieve the effect of unblocking the cell veins, promoting absorption, and obvious therapeutic effect

Inactive Publication Date: 2015-02-25
郭秀珍
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Chronic pelvic inflammatory disease is a common and frequently-occurring disease in gynecology. It has the characteristics of long course of disease, repeated attacks, and protracted and difficult to heal. It seriously affects the quality of life of patients, and even causes tubal adhesion and blockage leading to infertility. Caused by yang deficiency, in addition, women are currently overloaded with work, study, and entertainment, and their life patterns are becoming more and more unbalanced, causing endocrine disorders. Chronic pelvic inflammatory disease is very harmful. Due to pelvic blood stasis, patients may experience menstruation Increased cases; when the ovarian function is damaged, women will have menstrual disorders; when the fallopian tubes are adhered and blocked, it will lead to female infertility. Western medicine antibiotic treatment is effective in the short term, but the recurrence rate is high, and it is easy to cause endocrine disorders

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A kind of pharmaceutical composition for the treatment of chronic pelvic inflammatory disease, is made up of the following traditional Chinese medicine raw materials of proportioning by weight:

[0022] Shuanghuateng 30g, Patrinia 30g, Salvia 30g, Paeonolium 9g, Chishao 9g, Sanleng 9g, Curcuma 9g, Millipede 30g, Passepartout 30g, Forsythia 20g.

[0023] Above-mentioned pharmaceutical composition is made decoction preparation method as follows:

[0024] (1) Put the important raw materials of the above weight parts into the purple sand tank, add pure water, and it is advisable to add water to exceed the medicine surface 2cm. Before decocting, soak the above-mentioned Chinese medicine raw materials for 4 hours in winter and 2 hours in summer. its adequate moisture;

[0025] (2) Then boil on high heat for 10 minutes, pour out the medicinal liquid once, leave residue, continue to add cold water, it is advisable to add water to exceed 2m above the medicinal surface, switch t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating chronic pelvic inflammation. The pharmaceutical composition is prepared from the traditional Chinese medicine raw materials in parts by weight: 20-40 parts of honeysuckle stems, 20-40 parts of patrinia, 20-40 parts of salvia miltiorrhiza, 6-10 parts of cortex moutan, 6-10 parts of radix paeoniae rubra, 6-10 parts of rhizoma sparganii, 6-10 parts of curcuma zedoaria, 20-40 parts of suberect spatholobus stems, 20-40 parts of beautiful sweetgum fruits and 10-30 parts of fructus forsythiae. The pharmaceutical composition has the characteristics that blood stasis can be dispersed without blood injury because of the effects of invigorating the blood circulation and replenishing blood, the qi flow in channels is regulated, but is not consumed because of the effects of dispelling melancholy and regulating the qi flow in the channels, and finally, the stasis is dispersed and uterine vessels are circulated; and meanwhile, the pharmaceutical composition can be used for invigorating blood circulation and promoting diuresis, promoting uterine vessel circulation, promoting exudative inflammation absorption and adhered tissue looseness, relieving lesions, effectively relieving pelvic inflammation, salpingitis and hydrops conditions and promoting blood circulation to restore menstrual flow, and has a remarkable effect on treating hypogastric pain, lumbosacral aching pain, pelvic hydrops and infertility caused by fallopian tube obstruction caused by chronic pelvic inflammation.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a pharmaceutical composition for treating chronic pelvic inflammatory disease. Background technique [0002] Chronic pelvic inflammatory disease is a common and frequently-occurring disease in gynecology. It has the characteristics of long course of disease, repeated attacks, and protracted and difficult to heal. It seriously affects the quality of life of patients, and even causes tubal adhesion and blockage leading to infertility. Caused by yang deficiency, in addition, women are currently overloaded with work, study, and entertainment, and their life patterns are becoming more and more unbalanced, causing endocrine disorders. Chronic pelvic inflammatory disease is very harmful. Due to pelvic blood stasis, patients may experience menstruation When the ovarian function is damaged, women will have menstrual disorders; when the fallopian tubes are adhered and blocked, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P15/00A61P15/08
CPCA61K36/355A61K9/0014A61K9/0095A61K36/185A61K36/486A61K36/537A61K36/634A61K36/65A61K36/71A61K36/902A61K36/9066A61K2236/331A61K2236/39
Inventor 郭秀珍
Owner 郭秀珍
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products